Kinetic characteristics of acidic and alkaline ceramidase in human epidermis

Skin Pharmacology and Physiology

Volumn 20, Issue 4, 2007, Pages 187-194

  Houben, E ^a   Uchida, Y ^b   Nieuwenhuizen, W F ^c   De Paepe, K ^a   Vanhaecke, T ^a   Holleran, W M ^b   Rogiers, V ^a  

^a VRIJE UNIVERSITEIT BRUSSEL   (Belgium)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c TNO   (Netherlands)

Author keywords

Ceramidase; Epidermis; Kinetic parameters

Indexed keywords

ACYLSPHINGOSINE DEACYLASE; ENZYME INHIBITOR; ETHANOLAMINE DERIVATIVE; ISOENZYME;

ADULT; ARTICLE; ENZYME ACTIVITY; ENZYME ANALYSIS; ENZYME ASSAY; ENZYME INHIBITION; ENZYME KINETICS; ENZYME SUBSTRATE; ENZYMOLOGY; EPIDERMIS; FEMALE; HUMAN; HUMAN TISSUE; ISOENZYME ANALYSIS; ISOTOPE LABELING; NORMAL HUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; ZYMOGRAPHY;

ADULT; AMIDOHYDROLASES; ENZYME REPRESSION; EPIDERMIS; FEMALE; HUMANS; HYDROGEN-ION CONCENTRATION; ISOENZYMES; KINETICS; MIDDLE AGED; SKIN ABSORPTION;

EID: 34347212866     PISSN: 16605527     EISSN: None     Source Type: Journal    
DOI: 10.1159/000101388     Document Type: Article

References (35)

1. He X, Li CM, Park JH, Dagan A, Gatt S, Schuchman EH: A fluorescence-based highperformance liquid chromatographic assay to determine acid ceramidase activity. Anal Biochem 1999;274:264-269.
2. Linke T, Lansmann S, Sandhoff K: Purification of acid ceramidase from human placenta. Methods Enzymol 2000;311:201-207.
3. Momoi T, Ben Yoseph Y, Nadler HL: Substrate-specificities of acid and alkaline ceramidases in fibroblasts from patients with Farber disease and controls. Biochem J 1982;205:419-425.
4. Koch J, Gartner S, Li CM, Quintern LE, Bernardo K, Levran O, Schnabel D, Desnick RJ, Schuchman EH, Sandhoff K: Molecular cloning and characterization of a full-length complementary DNA encoding human acid ceramidase. Identification of the first molecular lesion causing Farber disease. J Biol Chem 1996;271:33110-33115.
5. Zhang Z, Mandal AK, Mital A, Popescu N, Zimonjic D, Moser A, Moser H, Mukherjee AB: Human acid ceramidase gene: novel mutations in Farber disease. Mol Genet Metab 2000;70:301-309.
6. El Bawab S, Roddy P, Qian T, Bielawska A, Lemasters JJ, Hannun YA: Molecular cloning and characterization of a human mitochondrial ceramidase. J Biol Chem 2000;275:21508-21513.
7. Hwang YH, Tani M, Nakagawa T, Okino N, Ito M: Subcellular localization of human neutral ceramidase expressed in HEK293 cells. Biochem Biophys Res Commun 2005;331:37-42.
8. Mao C, Xu R, Szulc ZM, Bielawska A, Galadari SH, Obeid LM: Cloning and characterization of a novel human alkaline ceramidase. A mammalian enzyme that hydrolyzes phytoceramide. J Biol Chem 2001;276:26577-26588.
9. Mao C, Xu R, Szulc ZM, Bielawski J, Becker KP, Bielawska A, Galadari SH, Hu W, Obeid LM: Cloning and characterization of a mouse endoplasmic reticulum alkaline ceramidase: an enzyme that preferentially regulates metabolism of very long chain ceramides. J Biol Chem 2003;278:31184-31191.
10. Houben E, Holleran WM, Yaginuma T, Mao C, Obeid LM, Rogiers V, Takagi Y, Elias PM, Uchida Y: Differentiation-associated expression of ceramidase isoforms in cultured keratinocytes and epidermis. J Lipid Res 2006;47:1063-1070.
11. Wakita H, Tokura Y, Yagi H, Nishimura K, Furukawa F, Takigawa M: Keratinocyte differentiation is induced by cell-permeant ceramides and its proliferation is promoted by sphingosine. Arch Dermatol Res 1994;286:350-354.
12. Jung EM, Griner RD, Mann-Blakeney R, Bollag WB: A potential role for ceramide in the regulation of mouse epidermal keratinocyte proliferation and differentiation. J Invest Dermatol 1998;110:318-323.
13. Gniadecki R, Gajkowska B, Bartosik J, Hansen M, Wulf HC: Variable expression of apoptotic phenotype in keratinocytes treated with ultraviolet radiation, ceramide, or suspended in semisolid methylcellulose. Acta Derm Venereol 1998;78:248-257.
14. Bektas M, Dullin Y, Wieder T, Kolter T, Sandhoff K, Brossmer R, Ihrig P, Orfanos CE, Geilen CC: Induction of apoptosis by synthetic ceramide analogues in the human keratinocyte cell line HaCaT. Exp Dermatol 1998;7:342-349.
15. Pillai S, Mahajan M, Carlomusto M: Ceramide potentiates, but sphingomyelin inhibits, vitamin D-induced keratinocyte differentiation: comparison between keratinocytes and HL-60 cells. Arch Dermatol Res 1999;291:284-289.
16. 3. Arch Dermatol Res 2000;292:455-462.
17. Di Nardo A, Benassi L, Magnoni C, Cossarizza A, Seidenari S, Giannetti A: Ceramide 2 (N-acetyl sphingosine) is associated with reduction in Bcl-2 protein levels by Western blotting and with apoptosis in cultured human keratinocytes. Br J Dermatol 2000;143:491-497.
18. Xia P, Wang L, Gamble JR, Vadas MA: Activation of sphingosine kinase by tumor necrosis factor-alpha inhibits apoptosis in human endothelial cells. J Biol Chem 1999;274:34499-34505.
19. 3 protects human keratinocytes from apoptosis by the formation of sphingosine-1-phosphate. J Invest Dermatol 2001;117:1241-1249.
20. Vogler R, Sauer B, Kim DS, Schafer-Korting M, Kleuser B: Sphingosine-1-phosphate and its potentially paradoxical effects on critical parameters of cutaneous wound healing. J Invest Dermatol 2003;120:693-700.
21. Sauer B, Vogler R, von Wenckstern H, Fujii M, Anzano MB, Glick AB, Schafer-Korting M, Roberts AB, Kleuser B: Involvement of Smad signaling in sphingosine 1-phosphate-mediated biological responses of keratinocytes. J Biol Chem 2004;279:38471-38479.
22. Hammer S, Sauer B, Spika I, Schraut C, Kleuser B, Schafer-Korting M: Glucocorticoids mediate differential anti-apoptotic effects in human fibroblasts and keratinocytes via sphingosine-1-phosphate formation. J Cell Biochem 2004;91:840-851.
23. Merrill AH, Wang E: Biosynthesis of longchain (sphingoid) bases from serine by LM cells. Evidence for introduction of the 4-trans-double bond after de novo biosynthesis of N-acylsphinganine(s). J Biol Chem 1986;261:3764-3769.
24. Rother J, van Echten G, Schwarzmann G, Sandhoff K: Biosynthesis of sphingolipids: dihydroceramide and not sphinganine is desaturated by cultured cells. Biochem Biophys Res Commun 1992;189:14-20.
25. Elias PM, Menon GK: Structural and lipid biochemical correlates of the epidermal permeability barrier. Adv Lipid Res 1991;24:1-26.
26. Elias PM, Feingold KR: Lipids and the epidermal water barrier: metabolism, regulation, and pathophysiology. Semin Dermatol 1992;11:176-182.
27. Bibel DJ, Aly R, Shinefield HR: Topical sphingolipids in antisepsis and antifungal therapy. Clin Exp Dermatol 1995;20:395-400.
28. Arikawa J, Ishibashi M, Kawashima M, Takagi Y, Ichikawa Y, Imokawa G: Decreased levels of sphingosine, a natural antimicrobial agent, may be associated with vulnerability of the stratum corneum from patients with atopic dermatitis to colonization by Staphylococcus aureus . J Invest Dermatol 2002;119:433-439.
29. Nieuwenhuizen WF, van Leeuwen S, Gotz F, Egmond MR: Synthesis of a novel fluorescent ceramide analogue and its use in the characterization of recombinant ceramidase from Pseudomonas aeruginosa PA01. Chem Phys Lipids 2002;114:181-191.
30. Bradford MM: A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of proteindye binding. Anal Biochem 1976;72:248-254.
31. Wertz PW, Downing DT: Ceramidase activity in porcine epidermis. FEBS Lett 1990;268:110-112.
32. Yada Y, Higuchi K, Imokawa G: Purification and biochemical characterization of membrane-bound epidermal ceramidases from guinea pig skin. J Biol Chem 1995;270:12677-12684.
33. Bernardo K, Hurwitz R, Zenk T, Desnick RJ, Ferlinz K, Schuchman EH, Sandhoff K: Purification, characterization, and biosynthesis of human acid ceramidase. J Biol Chem 1995;270:11098-11102.
34. Behne MJ, Meyer JW, Hanson KM, Barry NP, Murata S, Crumrine D, Clegg RW, Gratton E, Holleran WM, Elias PM, Mauro TM: NHE1 regulates the stratum corneum permeability barrier homeostasis. Microenvironment acidification assessed with fluorescence lifetime imaging. J Biol Chem 2002;277:47399-47406.
35. Behne MJ, Barry NP, Hanson KM, Aronchik I, Clegg RW, Gratton E, Feingold K, Holleran WM, Elias PM, Mauro TM: Neonatal development of the stratum corneum pH gradient: localization and mechanisms leading to emergence of optimal barrier function. J Invest Dermatol 2003;120:998-1006.